Skip to main content
. 2020 Nov 21;12(3):329–338. doi: 10.1111/1759-7714.13742

Figure 1.

Figure 1

The Kaplan‐Meier curve of progression‐free survival of osimertinib stratified according to the type of EGFR‐TKIs used for the treatment before osimertinib. (Inline graphic ) Group A; (Inline graphic ) Group B